导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.41% | 69/354 |
| 近一周 | -1.96% | 100/362 |
| 近一月 | -3.83% | 195/362 |
| 近一季 | -5.86% | 226/362 |
| 近半年 | 17.55% | 48/358 |
| 近一年 | 17.33% | 69/349 |
| 近两年 | 43.07% | 80/314 |
| 近三年 | 80.66% | 19/246 |
| 成立以来 | 433.71% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.10% 178/360 |
27.07% 22/366 |
- - |
- - |
| 2025 | 18.07% 161/358 |
-8.70% 293/340 |
16.97% 35/348 |
8.47% 163/354 |
1.92% 73/358 |
| 2024 | 22.73% 68/329 |
7.96% 75/280 |
7.58% 66/310 |
1.75% 218/318 |
3.85% 101/329 |
| 2023 | 51.56% 25/275 |
20.04% 3/205 |
14.38% 39/230 |
-3.06% 54/262 |
13.87% 23/276 |
| 2022 | -34.29% 146/201 |
-8.44% 56/153 |
-24.11% 151/164 |
-5.25% 72/189 |
-0.19% 154/202 |
| 2021 | 27.46% 18/150 |
1.52% 155/312 |
11.56% 45/328 |
1.12% 46/358 |
11.29% 16/151 |
| 2020 | 43.67% 7/103 |
-12.31% 150/280 |
29.68% 36/295 |
12.23% 32/299 |
12.57% 84/305 |
| 2019 | 38.70% 7/88 |
17.54% 28/258 |
4.04% 55/268 |
0.86% 117/253 |
12.45% 29/266 |
| 2018 | -1.97% 26/79 |
- - |
- - |
- - |
-18.08% 200/241 |
| 2017 | 30.67% 8/69 |
- - |
- - |
- - |
- - |
| 2016 | 3.79% 31/59 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 广发纳斯达克100ETF联接美元(QDII)A VS. 建信富时100指数(QDII)人民币A(539003) |